Fungal biofilm formation on cochlear implant hardware after antibiotic-induced fungal overgrowth within the middle ear

Pediatric Infectious Disease Journal

Volumn 23, Issue 8, 2004, Pages 774-778

  Cristobal, Ricardo ^a   Edmiston Jr , Charles E ^b   Runge Samuelson, Christina L ^a   Owen, Heather A ^a   Firszt, Jill B ^a   Wackym, P Ashley ^a,b  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Auditory neuropathy; Beckwith Wiedemann syndrome; Candida albicans; Cochlear implant; Complications; Fungal; Infections

Indexed keywords

CEFDINIR; OFLOXACIN;

ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL OVERGROWTH; BACTERIUM CONTAMINATION; BECKWITH WIEDEMANN SYNDROME; BIOFILM; CANDIDA; CASE REPORT; CHILD; CHRONIC OTITIS MEDIA; COCHLEA PROSTHESIS; DEVICE; DRUG INDUCED DISEASE; FEMALE; FUNGUS GROWTH; HEARING LOSS; HUMAN; INFECTION RISK; NEUROPATHY; OTITIS MEDIA; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; BECKWITH-WIEDEMANN SYNDROME; BIOFILMS; CANDIDA; CEPHALOSPORINS; COCHLEAR IMPLANTS; FEMALE; HUMANS; INFANT; OFLOXACIN; OTITIS MEDIA;

EID: 4043133715     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000134315.24413.92     Document Type: Article

References (25)

1. Belal A Jr. Contraindications to cochlear implantation. Am J Otol. 1986;7:172-175.
2. Post JC. Direct evidence of bacterial biofilms in otitis media. Laryngoscope. 2001;111:2083-2094.
3. Ehrlich GD, Veeh R, Wang X, et al. Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. JAMA. 2002;287:1710-1715.
4. Saidi IS, Biedlingmaier JF, Whelan P. In vivo resistance to bacterial biofilm formation on tympanostomy tubes as a function of tube material. Otolaryngol Head Neck Surg. 1999;120:621-627.
5. House WF, Luxford WM, Courtney B. Otitis media in children following the cochlear implant. Ear Hear. 1985;6(suppl):24S-26S.
6. Luntz M, Hodges AV, Balkany T, Dolan-Ash S, Schloffman J. Otitis media in children with cochlear implants. Laryngoscope. 1996;106: 1403-1405.
7. Seelig MS. The role of antibiotics in the pathogenesis of Candida infections. Am J Med. 1966;40:887-917.
8. Schrader N, Isaacson G. Fungal otitis externa: its association with fluoroquinolone eardrops. Pediatrics. 2003;111(5 pt 1):1123.
9. Schrader N, Isaacson G. Prevalence of resistant pathogens after ototopical fluoroquinolone use. Laryngoscope. In press.
10. Fradis M, Brodsky A, Ben-David J, Srugo I, Larboni J, Podoshin L. Chronic otitis media treated topically with ciprofloxacin or tobramycin. Arch Otolaryngol Head Neck Surg. 1997;123(10):1057-1060.
11. Goldblatt EL. Efficacy of ofloxacin and other otic preparations for acute otitis media in patients with tympanostomy tubes. Pediatr Infect Dis J. 2001;20:116-119 (discussion 120-121).
12. Davey ME, O'Toole GA. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev. 2000;64:847-867.
13. O'Toole G, Kaplan HB, Kolter R. Biofilm formation as microbial development. Annu Rev Microbiol. 2000;54:49-79.
14. Bachmann SP, VandeWalle K, Ramage G, et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother. 2002;46:3591-3596.
15. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol. 2001;183:5385-5394.
16. Ramage G, Wickes BL, Lopez-Ribot JL. Biofilms of Candida albicans and their associated resistance to antifungal agents. Am Clin Lab. 2001;20:42-44.
17. Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis: Infectious Diseases Society of America. Clin Infect Dis. 2000;30:662-678.
18. Daugbjerg P, Everberg G. A case of Beckwith-Wiedemann syndrome with conductive hearing loss. Acta Paediatr Scand. 1984;73:408-410.
19. Takahashi S, Shinoda H, Nakano Y. Congenital stapedial fixation associated with Beckwith-Wiedemann syndrome: two cases of a woman and her brother. Am J Otol. 1996;17:111-114.
20. Schick B, Brors D, Prescher A, Draf W. Conductive hearing loss in Beckwith-Wiedemann syndrome. Int J Pediatr Otorhinolaryngol. 1999; 48:175-179.
21. Wackym PA, Firszt JB, Gaggl W, Runge-Samuelson CL, Reeder RM, Raulie JC. Electrophysiologic effects of placing cochlear implant electrodes in a perimodiolar position in young children. Laryngoscope. 2004;114:71-76.
22. Chole RA, Faddis BT. Anatomical evidence of microbial biofilms in tonsillar tissues: a possible mechanism to explain chronicity. Arch Otolaryngol Head Neck Surg. 2003;129:634-636.
23. Ramage G, Saville SP, Wickes BL, Lopez-Ribot JL. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol. 2002;68:5459-5463.
24. Hawser SP, Douglas LJ. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun. 1994;62:915-921.
25. Arnold W, Bredberg G, Gstottner W, et al. Meningitis following cochlear implantation: pathomechanisms, clinical symptoms, conservative and surgical treatments. ORL J Otorhinolaryngol Relat Spec. 2002;64: 382-389.